Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate

Go back to Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
CBC Holding Company (NYSE: BHC) Delayed: 4.56 --0 (-0%)
Previous Close $4.56    52 Week High $4.75 
Open $4.56    52 Week Low $4.75 
Day High $4.56    P/E N/A 
Day Low $4.56    EPS $0.00 
Volume 1,302       

(NYSE: BLCO) Delayed: 15.95 --0 (-0%)
Previous Close $15.95    52 Week High
Open $15.95    52 Week Low
Day High $15.95    P/E N/A 
Day Low $15.95    EPS
Volume 15       

(NYSE: BLCO) Delayed: 15.95 --0 (-0%)
Previous Close $15.95    52 Week High
Open $15.95    52 Week Low
Day High $15.95    P/E N/A 
Day Low $15.95    EPS
Volume 15